References
- Johnson OL, Jaworowicz W, Cleland JL, et al. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res 1997;14:730–5
- Choy YB, Cheng F, Choi H, Kim KK. Monodisperse gelatin microspheres as a drug delivery vehicle: release profile and effect of crosslinking density. Macromol Biosci 2008;8:758–65
- Bae KH, Yoon JJ, Park TG. Fabrication of hyaluronic acid hydrogel beads for cell encapsulation. Biotechnol Prog 2006;22:297–302
- Jayant RD, Mcshane MJ, Srivastava R. Polyelectrolyte-coated alginate microspheres as drug delivery carriers for dexamethasone release. Drug Deliv 2009;16:331–40
- Powell EM, Sobarzo MR, Saltzman WM. Controlled release of nerve growth factor from a polymeric implant. Brain Res 1990;515:309–11
- Couvreur P. Polyalkylcyanoacrylate microspheres: a hepatic vector or a “furtive” vector. J Pharm Belg 2000;55:78–84
- Guerrero S, Muñíz E, Teijón C, et al. Ketotifen-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers: characterization and in vivo evaluation. J Pharm Sci 2008;97:3153–69
- Lee ES, Kwon MJ, Lee H, et al. In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate. Eur J Pharm Sci 2006;29:435–41
- Sengel-Turk CT, Hascicek C, Dogan AL, et al. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Drug Dev Ind Pharm 2012;38:1107–16
- Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsul 2005;22:57–66
- Zheng C, Liu X, Zhu J, Zhao Y. Preparation of cationic biodegradable dextran microspheres loaded with BSA and study on the mechanism of protein loading. Drug Dev Ind Pharm 2012;38:653–8
- Leo E, Ruozi B, Tosi G, Vandelli MA. PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated. Int J Pharm 2006;323:131–8
- Xu X, Yee WC, Hwang PY, et al. Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials 2003;24:2405–12
- Yu H, Peng J, Sun H, et al. Effect of controlled release nerve growth factor on repairing peripheral nerve defect by a cellular nerve graft. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2008;22:1373–7
- Fu K, Klibanov AM, Langer R. Protein stability in controlled realease systems. Nat Biotechnol 2000;18:24–5
- De Ruiter GCW, Spinner RJ, Yaszemski MJ, et al. Nerve tubes for peripheral nerve repair. Neurosurg Clin N Am 2009;20:91–105
- Xu X, Yu H, Gao S, et al. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. Biomaterials 2002;23:3765–72
- Péan JM, Venier-Julienne MC, Boury F, et al. NGF release from poly(d,l-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J Control Release 1998;56:175–87
- Cao X, Schoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999;20:329–39
- Péan JM, Boury F, Venier-Julienne MC, et al. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres? Pharm Res 1999;16:1294–9
- Rukenstein A, Greene LA. The quantitative bioassay of nerve growth factor use of frozen “primed” pc12 pheochromocytomacells. Brain Res 1983;263:177–80
- Pfister LA, Papaloïzos M, Merkle HP, Gander B. Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst 2007;12:65–82
- Wang W, Cai JF, Cao XC, Zhang Q. Injection of nerve growth factor-poly(lactic acid-glycolic acid) microcapsules into nerve guide conduits in repairing peripheral nerve defects. J Clin Rehabil Tissue Eng Res 2007;11:78–83
- Camarata PJ, Suryanarayanan R, Turner DA, et al. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 1992;30:313–19
- Rosner BI, Siegel RA, Grosberg A, et al. Rational design of contact guiding, neurotrophic matrices for peripheral nerve regeneration. Ann Biomed Eng 2003;31:1383–401
- Morita T, Horikiri Y, Suzuki T, Yoshino H. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir type microspheres. Eur J Pharm Biopharm 2001;51:45–53
- Zhao XL, Chen F, He C. The stability of 2.5 s nerve growth factor from mouse submaxillary glands. China Pharm 2001;4:308–9
- Lam XM, Duenas ET, Cleland JL. Encapsulation and stabilization of nerve growth factor into poly (lactic-co-glycilic) acid microspheres. J Pharm Sci 2001;90:1356–65
- Hadlock TA, Sheahan T, Cheney ML, et al. Biologic activity of nerve growth factor slowly released from microspheres. J Reconstr Microsurg 2003;19:179–84
- Wang YC, Zou QM. The application of biodegradable microspheres in protein drug delivery. Pharm J Chin People Liberation Army 2005;21:132–5
- Perugini P, Genta I, Pavanetto F, et al. Evaluation of enzyme stability during preparation of polylactide-co-glycolide microspheres. J Microencapsul 2002;19:591–602
- Cleland JL, Jones AJ. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm Res 1996;13:1464–75
- Sun HY, Xu FH, Guo DH, Yu HL. Preparation and evaluation of NGF-microsphere conduits for regeneration of defective nerves. Neurol Res 2012;34:491–7